Associated Papers
A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder Cancer.
Parada D et al.
Antioxidants (basel, Switzerland), 2026
Unveiling the Neuroprotective Effect of Paraoxonase 1 in Neurodegenerative Diseases Focusing on Alzheimer's Disease.
Ismail A et al.
Molecular Neurobiology, 2025
Newborn MTHFR rs1801133 Variant and Extremely Low Birth Weight: A Case-Control Study and Meta-Analysis.
Skulimowski B et al.
Genes, 2025
Impact of SNP Variants in PON-1 or UGT1A1 on Iron Chelation Therapy Outcomes and Zinc Status in Thalassemia Major Patients.
Lu MY et al.
Biological Trace Element Research, 2025
Paraoxonase 1 polymorphisms and their relationship with gastric cancer risk: a biochemical perspective on oxidative stress.
Najafi E et al.
Molecular Biology Reports, 2025
Investigating the role of the Pon1-rs854560 (L55M) SNP in colorectal Cancer susceptibility.
Wei X et al.
Journal of Cancer Research and Clinical Oncology, 2025
Association of CETP, APOA5, IL6, and PON1 Gene Variants with Dyslipidemia and Cardiovascular Risk in a Population from Cauca Department, Colombia.
Urbano-Cano AL et al.
Genes, 2025
Pon1 and Sult1a1 Polymorphisms and Breast Cancer Among Young Women in Brazil.
da Costa RSS et al.
Journal of Adolescent and Young Adult Oncology, 2025
Dantrolene is an HDL-associated paraoxonase-1 activator with immunosuppressive and atheroprotective properties.
Dedemadi AG et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids, 2025
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Kuras M et al.
Cancers, 2025
Association of Paraoxonase-1 (p.L55M) and Paraoxonase-2 (p.S311C) polymorphisms with coronary artery disease in North Indian Punjabi population.
Bhat MA et al.
Frontiers in Endocrinology, 2025
Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions-A Comprehensive Review.
Lewoń-Mrozek D et al.
International Journal of Molecular Sciences, 2024
The importance of paraoxonase 1 activity in chronic kidney disease.
Samouilidou EC et al.
Renal Failure, 2024
Determination of selected oxysterol levels, oxidative stress, and macrophage activation indicators in children and adolescents with familial hypercholesterolemia.
Canbay E et al.
Lipids in Health and Disease, 2024
Regulation of Human Hydrolases and Its Implications in Pharmacokinetics and Pharmacodynamics.
Jung SM et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2024
A Case-Control Study Supports Genetic Contribution of the PON Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease.
Van Dijck E et al.
Antioxidants (basel, Switzerland), 2024
PON1 rs662, rs854560 and TRIB1 rs17321515, rs2954029 Gene Polymorphisms Are Associated with Lipid Parameters in Patients with Unstable Angina.
Malinowski D et al.
Genes, 2024
Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD.
Shao C et al.
Hepatology Communications, 2024
PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study.
Ragkousis A et al.
Genes, 2024
ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation.
Enyedi EE et al.
Biomedicines, 2024
Association of PON1, APOE and SDF-1 Gene Polymorphisms with Treatment Response to Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion.
Ragkousis A et al.
Seminars in Ophthalmology, 2024
Single-Nucleotide Polymorphisms Associated with Mercury Levels and Neurological Symptoms: An Overview.
Perini JA et al.
Toxics, 2024
Role of PON1 L55M Gene Polymorphism in Parkinson's Disease among North Indian Population.
Kumar B et al.
Neurology India, 2024
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population.
Khasawneh LQ et al.
Human Genomics, 2024
The Regulatory Variant -108C/T in the Promoter of Paraoxonase 1 (PON1) Gene has a More Important Role in Regulating PON1 Activity Compared to rs3735590 in 3'-UTR in Patients with Coronary Artery Disease.
Zargari M et al.
Advanced Biomedical Research, 2024
Structural Characteristics of PON1 with Leu55Met and Gln192Arg Variants Influencing Oxidative-Stress-Related Diseases: An Integrated Molecular Modeling and Dynamics Study.
M S et al.
Medicina (kaunas, Lithuania), 2023
The associations of PON1 and APOE polymorphisms with plasma lipid levels and the risk for late complications in type 2 diabetes patients.
Klen J et al.
Journal of Medical Biochemistry, 2023
The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group.
Marjani A et al.
Hormone Molecular Biology and Clinical Investigation, 2023
Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome.
Pappa M et al.
Clinical Immunology (orlando, Fla.), 2023
Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease.
Menezes JF et al.
Scientific Reports, 2023
Proteomic Exploration of Paraoxonase 1 Function in Health and Disease.
Jakubowski H
International Journal of Molecular Sciences, 2023
Paraoxonase gene polymorphisms: Understanding the biochemical and genetic basis of coronary artery disease.
Nasreen FJ et al.
Journal of Taibah University Medical Sciences, 2023
Association between Genotype and the Glycemic Response to an Oral Glucose Tolerance Test: A Systematic Review.
Bayer S et al.
Nutrients, 2023
Association of APOE (rs429358 and rs7412) and PON1 (Q192R and L55M) Variants with Myocardial Infarction in the Pashtun Ethnic Population of Khyber Pakhtunkhwa, Pakistan.
Rahman N et al.
Genes, 2023
Do PON1-Q192R and PON1-L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity?
Yigittürk O et al.
Journal of Sport and Health Science, 2023
Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease.
Petrič B et al.
Antioxidants (basel, Switzerland), 2023
A common genetic variation in paraoxonase 1 and risk of breast cancer: a literature review, meta-analysis, and in silico analysis.
Karimian M
Nucleosides, Nucleotides & Nucleic Acids, 2023
Decoding the genetic relationship between Alzheimer's disease and type 2 diabetes: potential risk variants and future direction for North Africa.
Boukhalfa W et al.
Frontiers in Aging Neuroscience, 2023
Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.
Huang Q et al.
Peerj, 2023
Role of Single Nucleotide Polymorphism L55M in the Paraoxonase 1 Gene as a Risk and Prognostic Factor in Acute Coronary Syndrome.
Doneva-Basheva KI et al.
Current Issues in Molecular Biology, 2022
Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis.
Arida A et al.
Scientific Reports, 2022
Genetic variants of PON1, GSTM1, GSTT1, and locus 9p21.3, and the risk for premature coronary artery disease in Yucatan, Mexico.
García-González I et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council, 2022
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts.
Dagli-Hernandez C et al.
Pharmacological Reports : Pr, 2022
Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations.
Zarkasi KA et al.
International Journal of Environmental Research and Public Health, 2022
The effect of Paraoxonase gene polymorphisms and paraoxonase enzyme activity on Non-Hodgkin lymphoma.
Çınar E et al.
Nucleosides, Nucleotides & Nucleic Acids, 2022